TaiMed Biologics Inc. (TPEX: 4147)
Taiwan
· Delayed Price · Currency is TWD
74.70
+0.80 (1.08%)
Oct 11, 2024, 1:30 PM CST
TaiMed Biologics Revenue
TaiMed Biologics had revenue of 146.94M TWD in the quarter ending June 30, 2024, with 40.96% growth. This brings the company's revenue in the last twelve months to 641.66M, up 7.11% year-over-year. In the year 2023, TaiMed Biologics had annual revenue of 491.78M, down -12.65%.
Revenue (ttm)
641.66M
Revenue Growth
+7.11%
P/S Ratio
30.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
20.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 491.78M | -71.23M | -12.65% |
Dec 31, 2022 | 563.01M | 149.57M | 36.18% |
Dec 31, 2021 | 413.44M | -309.04M | -42.78% |
Dec 31, 2020 | 722.49M | 17.98M | 2.55% |
Dec 31, 2019 | 704.50M | 463.46M | 192.28% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition